National Lab Briefs

Fusion Controversy To Get Review Dissident physicist R Leonardo Mascheroni, who made headlines last year when he attacked the fusion research program at the Los Alamos National Laboratory, may finally get the technical review, he has demanded. The National Academy of Sciences has agreed to conduct a study for the Department of Energy on inertial confinement fusion programs, with a report due by September 1990. NAS officials say that the as-yet-unnamed panel will likely ask Mascheroni, who has

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Dissident physicist R Leonardo Mascheroni, who made headlines last year when he attacked the fusion research program at the Los Alamos National Laboratory, may finally get the technical review, he has demanded. The National Academy of Sciences has agreed to conduct a study for the Department of Energy on inertial confinement fusion programs, with a report due by September 1990. NAS officials say that the as-yet-unnamed panel will likely ask Mascheroni, who has remained unemployed since Los Alamos fired him in 1987, to present his view that the lab’s fusion program is based on lasers that are nearly 10 times too weak. Mascheroni believes that lasers generating at least 100 megajoules of power are necessary to drive a sustained fusion reaction, and he claims that he was dismissed by Los Alamos for objecting to a decision to focus exclusively on the smaller lasers. His case is being reviewed by the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies